×

Poxviral oncolytic vectors

  • US 9,180,150 B2
  • Filed: 11/17/2008
  • Issued: 11/10/2015
  • Est. Priority Date: 11/19/2007
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating a disease state, wherein a defective poxvirus whose genome is only defective of the F2L and JR2 genes is administered to a host organism or cell which is in need of such treatment.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×